EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

医学 克拉斯 内科学 肿瘤科 腺癌 肺癌 神经母细胞瘤RAS病毒癌基因同源物 T790米 队列 基因分型 肺 奥西默替尼 外显子 基因型 癌症 基因 遗传学 生物 结直肠癌
作者
Andrés Felipe Cardona,Leonardo Rojas,Zyanya Lucía Zatarain-Barrón,H. Freitas,Sara T. Granados,O. Castillo,George Oblitas,Luis Corrales,Christian David Castro,Alejandro Ruíz-Patiño,Claudio Marcelo Martin,María Angelina Pérez,Lisde González,Luis Chirinos,Carlos Alberto Vargas,Hernán Carranza,Jorge Miguel Otero,July Katherine Rodríguez,Jenny Rodriguez,Pilar Archila
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:125: 265-272 被引量:68
标识
DOI:10.1016/j.lungcan.2018.10.007
摘要

Contrasting other EGFR mutations (EGFRm) in lung adenocarcinomas, insertions in exon 20 (exon20ins) are generally associated with resistance to targeted therapy, limiting therapeutic options and impoverishing the prognosis compared to other EGFRm. We sought to extensively characterize exon20ins from a large cohort of lung adenocarcinomas in Hispanic patients.This was a region-wide, observational longitudinal cohort study to evaluate characteristics and outcomes of patients with exon20ins in lung adenocarcinoma, based on a secondary analysis of electronic records from the Geno1.2-CLICaP Platform and extended genotype testing. Patients from six Latin-American countries were included (Argentina, Colombia, Costa Rica, Ecuador, Panama, and Mexico). Data obtained included the molecular spectrum (extended genotyping for mutations in BRAF, NRAS, PIK3CA, Her2 and MEK1, as well as for EGFR amplification, ALK and PD-L1 protein expression), clinic-pathologic characteristics, prevalence and outcomes to therapeutic approach.4.005 patients diagnosed with stage III/IV lung adenocarcinoma from 2011 to 2016 were initially screened. Among these, 88 patients had a confirmed exon20 in. and were included; median age was 66-years, 62.5% were females, 64% were never smokers and 39% presented with brain metastases. The H773insH variant was the most frequent, making up 21.6% of cases. A common EGFRm was concomitantly found in 36.4% (del19/L858R), and 8% (G719X/L861Q/S768I) of cases. Five cases had additional mutations in PI3K, KRAS and MEK1, 26% had EGFR amplification and 81.7% had PD-L1 expression 1-50%. Overall response rate to first-line therapy was 28% and overall survival was 16.4 months. Prognosis was positively influenced by the concomitant presence of common EGFRm and response to first-line. Our results suggest that patients with EGFR exon20ins have similar clinical characteristics to those with common EGFRm but a poorer prognosis. Last, the mean PD-L1 expression in this population seems higher than for patients with common EGFRm.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被xiaomiii采纳,获得10
1秒前
1秒前
2秒前
整齐的访梦完成签到,获得积分10
2秒前
2秒前
桐桐的应助被惊霜采纳,获得10
3秒前
脑洞疼的应助被hebo采纳,获得10
3秒前
will完成签到,获得积分10
4秒前
我是老大的应助被笨笨松采纳,获得10
4秒前
4秒前
i坤发布了新的文献求助10
4秒前
6秒前
6秒前
cdercder的应助被Judy采纳,获得10
7秒前
111发布了新的文献求助10
7秒前
9秒前
9秒前
9秒前
10秒前
齐柏林飞飞鱼完成签到,获得积分10
11秒前
科研通AI65的应助被牧百川采纳,获得10
11秒前
好运发布了新的文献求助10
11秒前
11秒前
12秒前
初景发布了新的文献求助30
13秒前
13秒前
FashionBoy的应助被Dani采纳,获得10
13秒前
14秒前
WWWWB发布了新的文献求助10
14秒前
上官若男的应助被三金采纳,获得10
15秒前
完美世界的应助被可笑可笑采纳,获得10
15秒前
16秒前
16秒前
火huo完成签到 ,获得积分10
16秒前
小状元发布了新的文献求助10
17秒前
18秒前
18秒前
令狐惜海的应助被风趣乐天采纳,获得10
18秒前
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183381
求助须知:如何正确求助?哪些是违规求助? 9572627
关于积分的说明 21826833
捐赠科研通 7780405
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558177
邀请新用户注册赠送积分活动 2480309